- FoI Number
- 2023-467
- Subject
- Medications
- Date Received
- 03/11/2023
- Request and Response
-
1. In the past 3 months [latest 3 months available] how many patients have received the following treatments [for any disease]:
Berinert (Human C1-esterase inhibitor)
Cinryze (Human C1-esterase inhibitor)
Orladeyo (berotralstat)
Takhzyro (Lanadelumab)
Ruconest (Recombinant human C1-esterase inhibitor)
Firazyr (Icatibant injection)
Generic Icatibant Injection – any brand except Firazyr
Nil for all
